Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Acornmed

Acornmed provides clinical oncology solutions.
2019
11-50
Haidian, Beijing, China
OncologyPrecision Medicine

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

28.74M

Last Funding Amount

28.74M

Last Funding Date

27-12-2022

Startup Stage

Early Stage

Lead Investors

Sino-Ocean Group, Pickup Capital, Indaco Capital, Lingxian Ziben